PRISM BioLab Co.,LTD (TYO:206A)

Japan · Delayed Price · Currency is JPY

135.00

+6.00 (4.65%)

Jun 24, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023
Drug Discovery Business	677.33M	305.62M	112.93M
Drug Discovery Business Growth	121.62%	170.64%	-
Total	677.33M	305.62M	112.93M
Total Growth	121.62%	170.64%	-

Revenue by Geography

Financials in millions JPY. Fiscal year is October - September.

Millions JPY. Fiscal year is Oct - Sep.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023
Japan	110.00M	69.63M	68.04M
Japan Growth	57.98%	2.34%	-
United States of America	523.50M	219.20M	11.78M
United States of America Growth	138.82%	1761.56%	-
Switzerland	43.83M	16.79M	12.06M
Switzerland Growth	161.00%	39.24%	-
France	-	-	21.05M
Total	677.33M	305.62M	112.93M
Total Growth	121.62%	170.64%	-